{"id":"https://openalex.org/W4361237281","doi":"https://doi.org/10.1158/0008-5472.c.6508044","title":"Data from Secondary Tumors Arising in Patients Undergoing BRAF Inhibitor Therapy Exhibit Increased BRAF\u2013CRAF Heterodimerization","display_name":"Data from Secondary Tumors Arising in Patients Undergoing BRAF Inhibitor Therapy Exhibit Increased BRAF\u2013CRAF Heterodimerization","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361237281","doi":"https://doi.org/10.1158/0008-5472.c.6508044"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.c.6508044","doi":"https://doi.org/10.1158/0008-5472.c.6508044","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.c.6508044","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/0008-5472.c.6508044","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5003919808","display_name":"Lise Boussemart","orcid":"https://orcid.org/0000-0002-6895-0139","observed_orcids":["https://orcid.org/0000-0002-6895-0139","https://orcid.org/0009-0009-8792-8429","https://orcid.org/0000-0003-0935-3358"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lise Boussemart","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000095429","display_name":"Isabelle Girault","orcid":"https://orcid.org/0000-0002-9587-5197","observed_orcids":["https://orcid.org/0000-0002-9587-5197"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Isabelle Girault","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059950593","display_name":"H\u00e9l\u00e8ne Malka-Mahieu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H\u00e9l\u00e8ne Malka-Mahieu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009132075","display_name":"Christine Mateus","orcid":"https://orcid.org/0000-0002-4642-5982","observed_orcids":["https://orcid.org/0000-0002-4642-5982"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christine Mateus","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045815867","display_name":"\u00c9milie Routier","orcid":"https://orcid.org/0000-0001-5881-5956","observed_orcids":["https://orcid.org/0000-0001-5881-5956"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Emilie Routier","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074354589","display_name":"Margot Rubington","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Margot Rubington","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077195590","display_name":"Nyam Kamsu-Kom","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nyam Kamsu-Kom","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Marina Thomas","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marina Thomas","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052825528","display_name":"Gorana Tomasic","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gorana Tomasic","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086088982","display_name":"Sandrine Agoussi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sandrine Agoussi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073299970","display_name":"Marie Breckler","orcid":"https://orcid.org/0000-0001-6895-1361","observed_orcids":["https://orcid.org/0000-0001-6895-1361"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marie Breckler","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064195576","display_name":"M\u00e9lanie Laporte","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M\u00e9lanie Laporte","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003964504","display_name":"Ludovic Lacroix","orcid":"https://orcid.org/0000-0003-2535-1010","observed_orcids":["https://orcid.org/0000-0003-2535-1010"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ludovic Lacroix","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052579165","display_name":"Alexander M.M. Eggermont","orcid":"https://orcid.org/0000-0002-4278-040X","observed_orcids":["https://orcid.org/0000-0002-4278-040X","https://orcid.org/0000-0001-7458-4326"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexander M. Eggermont","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Andrea Cavalcanti","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrea Cavalcanti","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059800915","display_name":"Florent Grange","orcid":"https://orcid.org/0000-0003-3387-0283","observed_orcids":["https://orcid.org/0000-0003-3387-0283"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Florent Grange","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006476106","display_name":"Julien Adam","orcid":"https://orcid.org/0000-0001-7556-9101","observed_orcids":["https://orcid.org/0000-0001-7556-9101"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Julien Adam","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081632204","display_name":"St\u00e9phan Vagner","orcid":"https://orcid.org/0000-0003-1452-7164","observed_orcids":["https://orcid.org/0000-0003-1452-7164"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"St\u00e9phan Vagner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5100713900","display_name":"Caroline Robert","orcid":"https://orcid.org/0000-0002-9493-0238","observed_orcids":["https://orcid.org/0000-0002-9493-0238"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Caroline Robert","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9854000210762024,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9854000210762024,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","score":0.00570000009611249,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/braf-inhibitors","display_name":"BRAF inhibitors","score":0.9819999933242798},{"id":"https://openalex.org/keywords/secondary-tumors","display_name":"secondary tumors","score":0.593999981880188},{"id":"https://openalex.org/keywords/cutaneous-squamous-cell-carcinoma","display_name":"cutaneous squamous cell carcinoma","score":0.7229999899864197},{"id":"https://openalex.org/keywords/keratoacanthoma","display_name":"keratoacanthoma","score":0.8080000281333923},{"id":"https://openalex.org/keywords/ras-mutations","display_name":"RAS mutations","score":0.828000009059906},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.6759999990463257},{"id":"https://openalex.org/keywords/drug-induced-skin-toxicity","display_name":"drug-induced skin toxicity","score":0.5370000004768372},{"id":"https://openalex.org/keywords/proximity-ligation-assay","display_name":"proximity ligation assay","score":0.7979999780654907},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.5649999976158142},{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.9129999876022339}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6682978868484497},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6310089230537415},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5897879004478455},{"id":"https://openalex.org/C555283112","wikidata":"https://www.wikidata.org/wiki/Q1637543","display_name":"Carcinogenesis","level":3,"score":0.49075445532798767},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.47461003065109253},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.3287211060523987},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.29215767979621887}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/0008-5472.c.6508044","doi":"https://doi.org/10.1158/0008-5472.c.6508044","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.c.6508044","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.c.6508044","doi":"https://doi.org/10.1158/0008-5472.c.6508044","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.c.6508044","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2271023210","https://openalex.org/W2159866312","https://openalex.org/W2318725744","https://openalex.org/W4233152057","https://openalex.org/W4234318074","https://openalex.org/W2207106648","https://openalex.org/W2157210705","https://openalex.org/W1768812886","https://openalex.org/W1982968264","https://openalex.org/W2070645893"],"abstract_inverted_index":{"Abstract":[0],"BRAF":[1],"inhibitors":[2],"(BRAFi)":[3],"elicit":[4],"therapeutic":[5],"responses":[6],"in":[7,37,101,132],"metastatic":[8],"melanoma,":[9],"but":[10],"alarmingly,":[11],"also":[12],"induce":[13],"the":[14,26,92,104,112],"formation":[15,149],"of":[16,31,46,91,103,111,164],"secondary":[17],"benign":[18],"and":[19,28,34,58,84,86,109,156,167],"malignant":[20],"skin":[21,33],"tumors.":[22],"Here,":[23],"we":[24],"report":[25],"emergence":[27],"molecular":[29],"characterization":[30],"73":[32],"extracutaneous":[35,168],"tumors":[36,52,71,93,114],"31":[38],"patients":[39,47,65,116,138],"who":[40],"underwent":[41],"BRAFi":[42,120,154],"therapy.":[43],"The":[44],"majority":[45],"presented":[48],"with":[49,119,140,153],"classic":[50,75],"epidermal":[51],"such":[53,77],"as":[54,78,160],"verrucous":[55],"papillomas,":[56],"keratoacanthomas,":[57],"squamous":[59],"cell":[60],"carcinomas":[61],"(SCC).":[62],"However,":[63],"15":[64],"exhibited":[66],"new":[67,82],"or":[68],"rapidly":[69],"progressing":[70],"distinct":[72],"from":[73,115,136],"these":[74],"subtypes,":[76],"lymph":[79],"node":[80],"metastasis,":[81],"melanomas,":[83],"genital":[85],"oral":[87],"mucosal":[88],"SCCs.":[89],"Genotyping":[90],"revealed":[94],"that":[95,127,146],"oncogenic":[96],"RAS":[97],"mutations":[98],"were":[99],"found":[100],"58%":[102],"evaluable":[105],"tumor":[106,134,169],"samples":[107,135],"(38/66)":[108],"49%":[110],"control":[113],"not":[117],"treated":[118],"(30/62).":[121],"Notably,":[122],"proximity":[123],"ligation":[124],"assays":[125],"demonstrated":[126],"BRAF\u2013CRAF":[128,147],"heterodimerization":[129],"was":[130],"increased":[131],"fixed":[133],"BRAFi-treated":[137],"compared":[139],"untreated":[141],"patients.":[142],"Our":[143],"findings":[144],"reveal":[145],"complex":[148],"is":[150],"significantly":[151],"associated":[152],"treatment,":[155],"may":[157],"therefore":[158],"serve":[159],"a":[161],"useful":[162],"biomarker":[163],"BRAFi-induced":[165],"cutaneous":[166],"formation.":[170],"Cancer":[171],"Res;":[172],"76(6);":[173],"1476\u201384.":[174],"\u00a92016":[175],"AACR.":[176]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2023-03-31T00:00:00"}